Safety and efficacy of the NVX-CoV2373 COVID-19 vaccine at completion of the placebo-controlled phase of a randomized controlled trial

MLA

Paul T, Heath, et al. Safety and Efficacy of the NVX-CoV2373 COVID-19 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial. Feb. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....ceb2e01b1f99b5599959da54ff0d03b3&authtype=sso&custid=ns315887.

APA

Paul T, H., Eva P, G., David Neil, B., Marta, B., Duncan, B., Fiona, B., David R, C., Rebecca, C., Catherine A, C., James, G., Anna L, G., Amardeep, H., Andrew, H., Shalini, I., Christopher, J., Philip A, K., Christina, K., Judy M, B., Chigomezgo, M., … Seth, T. (2023). Safety and efficacy of the NVX-CoV2373 COVID-19 vaccine at completion of the placebo-controlled phase of a randomized controlled trial.

Chicago

Paul T, Heath, Galiza Eva P, Baxter David Neil, Boffito Marta, Browne Duncan, Burns Fiona, Chadwick David R, et al. 2023. “Safety and Efficacy of the NVX-CoV2373 COVID-19 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial,” February. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....ceb2e01b1f99b5599959da54ff0d03b3&authtype=sso&custid=ns315887.